文献速递胸部CT

CT定义的胸肌密度可预测COVID-19住院患者30天死亡率:一项全国多中心研究

CT-Defined Pectoralis Muscle Density Predicts 30-Day Mortality in Hospitalized Patients with COVID-19: A Nationwide Multicenter Study.
PubMed 文献 · Acad Radiol · 2024-12-15

本研究为德国RACOON多中心回顾性研究的一部分,纳入1379例COVID-19住院患者(女389例,男990例),分析胸部CT计算的胸肌面积和密度与30天死亡率的关系。结果显示30天死亡率为17.9%,低胸肌密度(LPMD)是30天死亡率的独立预测因子(HR=2.97,95%CI 1.52-5.80,p=0.001),在男性患者中同样独立预测(HR=2.96,95%CI 1.42-6.18,p=0.004),但在女性患者中胸肌参数不能预测30天死亡率。

要点

  • 低胸肌密度是COVID-19住院患者30天死亡率的独立预测因子(HR=2.97)。
  • 男性患者中低胸肌密度独立预测30天死亡率(HR=2.96)。
  • 女性患者中胸肌参数不能预测30天死亡率。

核心结论

  • 在男性COVID-19患者中,低胸肌密度与30天死亡率强烈相关,可用于风险分层;在女性患者中,胸肌参数不能预测30天死亡率。

研究设计与样本

  • 德国RACOON多中心项目的一部分,回顾性研究,纳入1379例患者(女389例,28.2%;男990例,71.8%),分析胸部CT计算的胸肌面积和密度,采用描述性统计、Mann-Whitney U检验、Fisher精确检验及单变量和多变量逻辑回归分析。

诊断标准与关键数值

  • 以中位数作为阈值定义低胸肌密度(LPMD);LPMD预测30天死亡率:HR=2.97,95%CI 1.52-5.80,p=0.001;男性患者中HR=2.96,95%CI 1.42-6.18,p=0.004;60岁以下患者中HR=2.72,95%CI 1.17-6.30,p=0.019。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: The prognostic role of computed tomography (CT)-defined skeletal muscle features in COVID-19 is still under investigation. The aim of the present study was to evaluate the prognostic role of CT-defined skeletal muscle area and density in patients with COVID-19 in a multicenter setting.

MATERIALS AND METHODS: This retrospective study is a part of the German multicenter project RACOON (Radiological Cooperative Network of the COVID-19 pandemic). The acquired sample included 1379 patients, 389 (28.2%) women and 990 (71.8%) men. In each case, chest CT was analyzed and pectoralis muscle area and density were calculated. Data were analyzed by means of descriptive statistics. Group differences were calculated using the Mann-Whitney-U test and Fisher's exact test. Univariable and multivariable logistic regression analyses were performed.

RESULTS: The 30-day mortality was 17.9%. Using median values as thresholds, low pectoralis muscle density (LPMD) was a strong and independent predictor of 30-day mortality, HR=2.97, 95%-CI: 1.52-5.80, p=0.001. Also in male patients, LPMD predicted independently 30-day mortality, HR=2.96, 95%-CI: 1.42-6.18, p=0.004. In female patients, the analyzed pectoralis muscle parameters did not predict 30-day mortality. For patients under 60 years of age, LPMD was strongly associated with 30-day mortality, HR=2.72, 95%-CI: 1.17;6.30, p=0.019. For patients over 60 years of age, pectoralis muscle parameters could not predict 30-day mortality.

CONCLUSION: In male patients with COVID-19, low pectoralis muscle density is strongly associated with 30-day mortality and can be used for risk stratification. In female patients with COVID-19, pectoralis muscle parameters cannot predict 30-day mortality.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Bucher AM, Behrend J, Ehrengut C, et al. CT-Defined Pectoralis Muscle Density Predicts 30-Day Mortality in Hospitalized Patients with COVID-19: A Nationwide Multicenter Study. Acad Radiol. 2024. PMID: 39675998. doi:10.1016/j.acra.2024.11.054

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。